Pharmas / CROs
Belle accelerates time-to-market for new skin health therapies by powering decentralized clinical trials
with accurate AI-supported image analysis
Unlock the cost savings and speed of digital endpoints.
Replace in-person, infrequent, and high-cost direct
evaluation with cost effective digital assessment from smartphone photos
Focus investigators’ time on high-value work.
Maximize scarce resources by automating severity scoring of
psoriasis, eczema, vitiligo, alopecia areata, acne, and other diseases
Quickly acquire trial subjects.
Qualify patients anywhere using smartphone photos
Increase patient engagement and retention.
Make it easy for patients to see authentic results and motivate them to continue treatment
eCOA, and ePRO: Capture and lock data to support clinical and patient reported outcomes